Genelux Corp falls on $18 mln private placement
** Shares of biopharmaceutical co Genelux Corporation
GNLX.O down 4.4% at $26.61 premarket
** Co announces $18 mln private placement through issuance
of its 900,000 shares at $20.00/shr, reflecting a nearly 28.2%
discount on stock's last close
** Says proceeds to extend co's cash runway into the first
quarter of 2026
** As of the last close, stock trading flat YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Genelux
See all newsGenelux posts wider-than-expected Q2 loss on higher R&D expenses
Genelux Corp expected to post a loss of 20 cents a share - Earnings Preview
Genelux Q1 net loss widens, misses analyst expectations
Brief: Genelux Corporation Announces Pricing Of $20.0 Million Underwritten Public Offering Of Common Stock
Brief: Genelux Corporation Announces Proposed Public Offering of Common Stock